BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2005
View Archived Issues
New data on the effects of topical ATL-1101 in mild to moderate psoriasis
Read More
Bazedoxifene's actions in animal models of osteoporosis
Read More
In vitro data on laquinimod, an experimental drug for MS
Read More
Adventrx inlicenses novel emulsion formulation of vinorelbine tartrate
Read More
Rejuvenon renames itself Sapphire Therapeutics
Read More
ChemGenex studies Ceflatonin in Gleevec-resistant CML
Read More
Provectus cleared for phase I study of PV-10 for recurrent breast cancer
Read More
Positive phase III data for ALGRX-3268 local anesthetic
Read More
ActivBiotics to study rifalazil for PAD in phase III trial
Read More
Telik to begin clinical studies with oral Telintra
Read More
Phase III program begins for tobramycin inhalation powder in cystic fibrosis
Read More
Genzyme licenses CML markers from UCLA
Read More
GenVec and Vaccine Research Center HIV research program boosted by investment
Read More
Aastrom Biosciences begins clinical trials with Tissue Repair Cells for limb ischemia
Read More
Cerus and The University of New Mexico to develop tularemia vaccine
Read More
Trillium gains immunology-related portfolio through Arthron acquisition
Read More
Reliant announces U.S. launch of Omacor as diet supplement for very high TG
Read More
BioArctic and Abmaxis establish alliance for Alzheimer's disease
Read More
Comparative study of retapamulin's antimicrobial activity
Read More
Mechanisms underlying Valortim's potency and durability against anthrax
Read More
Lilly profiles mGlu2/3 receptor agonist parent and prodrug studies
Read More
Neuroprotective effects of NAP in MS
Read More
Recent patents cover novel treatments for Parkinson's disease, Alzheimer's disease, etc.
Read More
New therapeutics for cancer claimed in recent patents
Read More
Therapeutics and diagnostics for arthritis in early development
Read More
Promising results reported for LB-03002 in children with GHD
Read More
Gardasil reported to reduce the risk of HPV-associated cervical neoplasia
Read More
New data on the role of mGlu receptors in schizophrenia and anxiety disorders
Read More
Davanat increases the antitumor efficacy of 5-FU in patients with solid tumors
Read More